Low dose systemic or intralesional meglumine antimoniate treatment for American tegumentary leishmaniasis results in low lethality, low incidence of relapse, and low late mucosal involvement in a referral centre in Rio de Janeiro, Brazil (2001-2013)

BACKGROUND: American tegumentary leishmaniasis (ATL) is a non-lethal parasitic disease that presents with cutaneous (CL) and mucosal (ML) clinical forms. ATL treatment aims at healing the lesions and preventing the development of the late mucosal form. Systemic meglumine antimoniate (MA) therapy wit...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mem Inst Oswaldo Cruz
Autors principals: Brahim, Lucia Regina, Valete-Rosalino, Cláudia Maria, Antônio, Liliane de Fátima, Pimentel, Maria Inês Fernandes, Lyra, Marcelo Rosandiski, Paes, Luiz Eduardo de Carvalho, da Costa, Ananda Dutra, Vieira, Iracema Forni, Dias, Cristina Maria Giordano, Duque, Maria Cristina de Oliveira, Marzochi, Mauro Celio de Almeida, Schubach, Armando de Oliveira
Format: Artigo
Idioma:Inglês
Publicat: Instituto Oswaldo Cruz, Ministério da Saúde 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5719553/
https://ncbi.nlm.nih.gov/pubmed/29211245
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/0074-02760160478
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars